Kybella

Also known as: deoxycholic acid injection, atx-101, belkyra, belkira, kybela, kyballa, kybelia, double chin injection, submental fat dissolving injection, injectable fat reduction

Body Contouring & Cellulite

AI Aesthetician Summary

Kybella (deoxycholic acid injection) is a first-in-class, FDA-approved injectable treatment specifically designed to reduce moderate to severe submental fat, commonly known as a "double chin". Also marketed as Belkyra in Canada and previously known as ATX-101 during clinical development, this minima...

Treatment Details

Targets

Concerns:Double Chin Excess Fat Sagging Jawline

Areas:Chin, Neck, Jaw

Tissues:Subcutaneous Fat

Longevity:Permanent

How it Works

Duration:15 minutes

Anesthesia:Local Injection

Pain Level:Moderate

Techniques:Injection

Multiple Sessions:Yes

Session Notes:Typically 2-4 sessions (up to 6) are required, spaced 4-6 weeks apart (minimum 1 month) to allow swelling to subside and results to become apparent.

Post Treatment

Downtime:14 days

Post-care:After Kybella treatment, manage swelling and pain with ice packs and over-the-counter acetaminophen, avoiding NSAIDs like ibuprofen. Elevate your head while sleeping for 3-5 days and avoid strenuous exercise for at least 48 hours to minimize swelling. Swelling is common and typically peaks within 24-48 hours, gradually subsiding over 1-2 weeks, though some firmness may persist.

Risks:Common: Swelling, bruising, pain, numbness, redness, hardness in the treatment area. Serious: Nerve injury in the jaw (uneven smile, facial muscle weakness), trouble swallowing (dysphagia), skin ulceration or necrosis, allergic reactions, temporary hair loss at injection sites, injection site infection.

Additional Information

Invasiveness:Minimally Invasive

Manufacturer:Allergan Aesthetics

Specialty:Medical Spa

Research